SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-292028
Filing Date
2022-11-23
Accepted
2022-11-23 16:12:17
Documents
17
Period of Report
2022-11-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d240360d8k.htm   iXBRL 8-K 37767
2 EX-1.1 d240360dex11.htm EX-1.1 244613
3 EX-4.1 d240360dex41.htm EX-4.1 67224
4 EX-5.1 d240360dex51.htm EX-5.1 17229
8 GRAPHIC g240360dsp65.jpg GRAPHIC 4096
9 GRAPHIC g240360dsp66.jpg GRAPHIC 2369
  Complete submission text file 0001193125-22-292028.txt   595941

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA scph-20221122.xsd EX-101.SCH 2882
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20221122_lab.xml EX-101.LAB 18739
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20221122_pre.xml EX-101.PRE 11729
11 EXTRACTED XBRL INSTANCE DOCUMENT d240360d8k_htm.xml XML 3461
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 221416465
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences